MedTech News
.................... by Andrew Celentano
Airiver Medical Granted FDA’s Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis
BROOKLYN PARK, Minn., March 4, 2026 /PRNewswire/ — Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its Airiver Pulmonary Drug Coated Balloon (DCB) to treat central airway stenosis.
Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors
MINNETONKA, Minn., March 4, 2026 /PRNewswire/ — Monteris Medical, the leader in minimally invasive neurosurgical technology with its NeuroBlate® System, announced today that a newly published randomized prospective study in the distinguished journal Nature Communications suggests that laser interstitial thermal therapy (LITT) using NeuroBlate may enhance the effectiveness of the immunotherapy drug pembrolizumab (Keytruda®) for patients with recurrent high grade astrocytoma, including glioblastoma (GBM).
Team develops 3D-printed bandage to help heal chronic wounds
A team of University of Mississippi researchers is developing a way to use 3D-printed medicated patches to help close persistent sores and ulcers
Novel imaging tracer reveals how tumors use fat to grow
A new King’s College London study introduces a brand-new imaging tracer that looks at how tumors use fats to fuel their growth
Study finds stress-related nerves may fuel pancreatic cancer growth
Oregon Health & Science University researchers have found that certain nerves that play an integral role in the body’s “fight or flight” stress response can support pancreatic tumor growth.
‘Mini hearts’ show COVID-19 virus directly infects heart tissue
Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID-19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
OSLO, Norway, March 3, 2026 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that its core product APL-1702 (trade name: CEVIRA®), has received the Drug Registration Certificate from China’s National Medical Products Administration (NMPA), enabling commercial launch in China.